Abstract：Objective To explore an optimal oxygen saturation for extremely preterm infants based on a systemic review of the published studies. Methods A Meta analysis of the published studies by the NeOProM Group which compared the outcomes of extremely preterm infants (gestational age < 28 weeks) maintained in either a low (85%-89%) or high (91%-95%) oxygen saturation (SpO2) by using the STATA 12.0. The outcomes measured included the mortality and the incidences of retinopathy of prematurity (ROP), necrotizing enterocolitis of newborn (NEC), broncho-pulmonary dysplasia (BPD), intraventricular hemorrhage (IVH) and patent ductus arteriosus (PDA). Results Three studies were included, in which 2 460 infants were assigned into the low SpO2 group and 2 459 infants in the high SpO2 group. The Meta analysis demonstrated that the risk of mortality before discharge or at the age of 18 months increased in the low SpO2 group compared with the high SpO2 group (RR: 1.19; 95%CI: 1.05-1.35); the risk of ROP decreased in the low SpO2 group (RR: 0.73; 95%CI: 0.53-1.00); the risk of NEC increased in the low SpO2 group (RR: 1.26; 95%CI: 1.06-1.49). There was no significance in the incidences of BPD, IVH and PDA between the two groups. Conclusions Maintaining SpO2 at 85%-89% may decrease the incidence of ROP, but increase the mortality rate and the incidence of NEC in extremely premature infants.
LI Jing-Yang,LIN Zhen-Lang,WEI Jia et al. What is the optimal oxygen saturation for extremely premature infants? A Meta analysis[J]. CJCP, 2015, 17(2): 128-133.
Askie LM, Henderson-Smart DJ, Ko H. Restricted versus liberal oxygen exposure for preventing morbidity and mortality in preterm or low birth weight[J]. Cochrane Database Syst Rev, 2009, (1): CD001077.
[2]
Jobe AH, Bancalari E. Bronchopulmonary dysplasia[J]. Am J Respir Crit Care Med, 2001, 163(7): 1723-1729.
[3]
Warner BB, Stuart LA, Papes RA, et al. Functional and pathological effects of prolonged hyperoxia in neonatal mice[J]. Am J Physiol, 1998, 275 (1 Pt 1): L110-L117.
[4]
Collins MP, Lorenz JM, Jetton JR, et al. Hypocapnia and other ventilation-related risk factors for cerebral palsy in low birth weight infants[J]. Pediatr Res, 2001, 50 (6): 712-719.
[5]
Chow LC, Wright KW, Sola A. Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants?[J]. Pediatrics, 2003, 111(2): 339-345.
[6]
Tin W, Milligan DW, Pennefather P, et al. Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation [J]. Arch Dis Child Fetal Neonatal Ed, 2001, 84(2): F106-F110.
[7]
The STOP-ROP Multicenter Study Group. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP). a randomized, controlled trial. I: primary outcomes [J]. Pediatrics, 2000, 105(2): 295-310.
BOOST II United Kingdom Collaborative Group, BOOST II Australia Collaborative Group, BOOST II New Zealand Collaborative Group, et al. Oxygen saturation and outcomes in preterm infants [J]. N Engl J Med, 2013, 368(22): 2094-2104.
[10]
Carlo WA, Finer NN, Walsh MC, et al. Target ranges of oxygen saturation in extremely preterm infants [J]. N Engl J Med, 2010, 362(21): 1959-1969.
[11]
Schmidt B, Whyte RK, Asztalos EV, et al. Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized clinical trial [J]. JAMA, 2013, 309(20): 2111-2120.
[12]
Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.17[updated Dec 2008] [DB /OL]. The Cochrane Collaboration, 2008. Available at www. Cochranehandbook.org.
Stenson B, Brocklehurst P, Tarnow-Mordi W, et al. Increased 36-week survival with high oxygen saturation target in extremely preterm infants [J]. N Engl J Med, 2011, 364(17): 1680-1682.
[15]
Early Treatment For Retinopathy Of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial[J]. Arch Ophthalmol, 2003, 121(12): 1684-1694.
[16]
Silverman WA. A cautionary tale about supplemental oxygen: the albatross of neonatal medicine[J]. Pediatrics, 2004, 113(2): 394-396.
[17]
Anderson CG, Benitz WE, Madan A. Retinopathy of prematurity and pulse oximetry: a national survey of recent practices [J]. J Perinatol, 2004, 24(3): 164-168.
[18]
Saugstad OD, Aune D. Optimal oxygenation of extremely low birth weight infants: a meta-analysis and systematic review of the oxygen saturation target studies[J]. Neonatology, 2014, 105(1): 55-63.
Myers TR, American Association for Respiratory Care. AARC Clinical Practice Guideline: selection of an oxygen delivery device for neonatal and pediatric patients--2002 revision & update [J]. Respir Care, 2002, 47(6): 707-716.
